Anzhelika Marsovna Milichkina

Anzhelika Marsovna Milichkina

Auto-generated profile, based on publicly available information

Anzhelika Marsovna Milichkina

Saint Petersburg Pasteur Institute

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 December 2024 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
APAnna Yurievna Popova
Anna Yurievna Popova
SESvetlana Alexandrovna Egorova
Svetlana Alexandrovna Egorova
VSViacheslav Smirnov
Viacheslav Smirnov
EEElena Borisovna Ezhlova
Elena Borisovna Ezhlova
AMAnzhelika Marsovna Milichkina
Anzhelika Marsovna Milichkina
БВБуц Людмила Васильевна
Буц Людмила Васильевна
Specific measles, mumps, and rubella prevention has been the main prerequisite for a striking decline in the incidence of such infections in Russia. An increase in the percentage of seronegative individuals observed in recent years resulted in higher measles incidence being directly related to low herd immunity that accounts for a population protection solely under conditions of a high density of immunized individuals and their uniform distribution in the population. The number of immunized individuals may be estimated only while conducting seroepidemiological monitoring of herd immunity. The objective of the study was to assess a level of herd immunity in the St. Petersburg and Leningrad Region population against measles, mumps, and rubella viruses. Materials and methods. There were enrolled 6774 residents into the study: volunteers aged from 1 to 70+ years. The representativeness of the surveyed cohort was ensured by using the Web application “Monitoring of herd immunity against socially significant infections”, used at the stage of volunteer enrollment, by randomization and regulation of the sample size in age groups. Participants filled out a questionnaire and agreed to provide venous blood samples to assess IgG antibody levels against measles, mumps, and rubella viruses by using ELISA. Results. In September 2023, in St. Petersburg and the Leningrad Region, herd immunity met the criterion for epidemiological well-being only with respect to rubella. In all age groups, the proportion of seronegative individuals did not exceed 15%, and most volunteers had high Ab levels, both after illness and vaccination. For measles and mumps, the criterion for epidemiological well-being is considered not to exceed more than 7% seronegative individuals. A sufficient level of measles seroprevalence was detected only in older age groups (≥ 60 years old). Sufficient mumps seroprevalence was not detected in any age group. The average population (St. Petersburg, Leningrad Region) seroprevalence magnitude for measles, rubella, and mumps viruses were 81.4%, 95.5%, and 78.4%, respectively. The problematic age groups with low measles seroprevalence (62.4–74.3%) were adolescents (12–17 years) and young adults (18–39 years). Most seropositive individuals vaccinated against measles had low Ab levels; high levels were noted mainly in older measles convalescent individuals. Low mumps seroprevalence (~70%) was more often observed among adults aged 18 to 49 years. The distribution of seroprevalence in various occupational group was relatively uniform, with some predominance of seropositivity among pensioners and schoolchildren. Conclusion. The system of specific prophylaxis for vaccine-preventable viral infections used in Russia has shown high efficacy and contributed to the formation of herd immunity, which for many years allowed to lower a risk of both sporadic and group infections to minimal levels. Currently, measles and mumps seroprevalence in the local population is maintained at insufficient level to ensure epidemiological well-being. This necessitates making appropriate management decisions and conducting additional preventive measures aimed at enhancing relevant herd immunity.

2 July 2022 in Medical Microbiology and Immunology
Verified
Journal Article
Open access
PDF file
APAnna Y Popova
Anna Y Popova
OKOmor T Kasymov
Omor T Kasymov
VSVyacheslav Y Smolenski
Vyacheslav Y Smolenski
VSViacheslav Smirnov
Viacheslav Smirnov
SESvetlana Alexandrovna Egorova
Svetlana Alexandrovna Egorova
ATAreg Artemovich Totolian
Areg Artemovich Totolian
In the fight against coronavirus infection, control of the immune response is of decisive importance, an important component of which is the seroprevalence of antibodies to SARS-CoV-2. Immunity to SARS-CoV-2 is formed either naturally or artificially through vaccination. The purpose of this study was to assess the seroprevalence of antibodies to SARS-CoV-2 in the population of Kyrgyzstan. A cross-sectional randomized study of seroprevalence was carried out according to a program developed by Rospotrebnadzor and the St. Petersburg Pasteur Institute, taking into account WHO recommendations. The ethics committees of the Association of Preventive Medicine (Kyrgyzstan) and the St. Petersburg Pasteur Institute (Russia) approved the study. Volunteers (9471) were recruited, representing 0.15% (95% CI 0.14–0.15) of the total population, randomized by age and region. Plasma antibodies (Abs) to the nucleocapsid antigen (Nag) were determined. In vaccinated individuals, Abs to the SARS-CoV-2 receptor-binding domain antigen (RBDag) were determined. Differences were considered statistically significant at p < 0.05. The SARS-CoV-2 Nag Ab seroprevalence was 48.7% (95% CI 47.7–49.7), with a maximum in the 60–69 age group [59.2% (95% CI 56.6–61.7)] and a minimum in group 1–17 years old [32.7% (95 CI: 29.4–36.1)]. The highest proportion of seropositive individuals was in the Naryn region [53.3% (95% CI 49.8–56.8)]. The lowest share was in Osh City [38.1% (95% CI 32.6–43.9)]. The maximum SARS-CoV-2 Nag seropositivity was found in the health-care sector [57.1% (95% CI 55.4–58.8)]; the minimum was seen among artists [38.6% (95% CI 26.0–52.4)]. Asymptomatic SARS-CoV-2 Nag seropositivity was 77.1% (95% CI 75.6–78.5). Vaccination with Sputnik V or Sinopharm produced comparable Ab seroprevalence. SARS-CoV-2 Nag seropositivity in the Kyrgyz population was 48.75% (95% CI 47.7–49.7), with the mass vaccination campaign undoubtedly benefitting the overall situation.

13 April 2020 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
OHOncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology
Oncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology
NKN.B. Kuzmenko
N.B. Kuzmenko
YRYulia Rodina
Yulia Rodina
AKA.L. Khoreva
A.L. Khoreva
AMA.A. Moiseeva
A.A. Moiseeva
ARA.G. Rumyantsev
A.G. Rumyantsev
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.

10 June 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
OHOncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology
Oncology And Immunology Named After Dmitry Rogachev National Scientific And Practical Center For Pediatric Hematology
NKN.B. Kuzmenko
N.B. Kuzmenko
YRYulia Rodina
Yulia Rodina
IKI.V. Kondratenko
I.V. Kondratenko
АBА.а. Bologov
А.а. Bologov
IEIrkutsk Irkutsk State Medical Academy Of Postgraduate Education - Subsidiary Of The Russian Medical Academy For Continuous Professional Education
Irkutsk Irkutsk State Medical Academy Of Postgraduate Education - Subsidiary Of The Russian Medical Academy For Continuous Professional Education
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.

7 October 2021 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
APA. Yu. Popova
A. Yu. Popova
ATA. A. Tarasenko
A. A. Tarasenko
VSV. Yu. Smolensky
V. Yu. Smolensky
SESvetlana Alexandrovna Egorova
Svetlana Alexandrovna Egorova
VSViacheslav Smirnov
Viacheslav Smirnov
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Objective was to investigate the SARS-CoV-2 collective immunity status of the population of Belarus within the context of the COVID-19 pandemic. Materials and methods. The work was carried out according to the methodology for assessing SARS-CoV-2 population immunity, developed by Rospotrebnadzor Russia and the Ministry of Health of Belarus with the participation of the St. Petersburg Pasteur Institute, taking into account WHO recommendations. The Bioethics Committee of Belarus and the local ethics committee of the St. Petersburg Pasteur Institute approved the study. Selection of participants was carried out using a questionnaire method and online technology (internet, cloud server). Volunteers were randomized into seven age groups (years of age): 1–17; 18–29; 30–39; 40–49; 50–59; 60–69; and 70+. Regional randomization ensured proportional representation of volunteers from each region, and no more than 30 people were included from one enterprise. In accordance with manufacturer instructions, blood plasma samples were analyzed for: IgG antibodies (Abs) to the SARS-CoV-2 nucleocapsid (Nc) using a quantitative ELISA test system; and IgG Abs to the receptor binding domain (RBD) of the SARS-CoV-2 S (spike) surface glycoprotein using a qualitative ELISA test system. Statistical processing was carried out using Excel 2010 and other software. Statistical differences were designated as significant when p 0.05, unless otherwise indicated. Results. The level of seroprevalence, in terms of Abs to Nc among the Belarusian population, was 38.4% (95% CI 37.6–45.4). The highest Ab levels were found among individuals in older age groups (50-70+ years old). The lowest were found in children 1–17 years old and in young people 18–39 years old The distribution of seroprevalence across Belarusian regions was relatively homogeneous, with the exception of the Minsk Region, where a statistically significant decrease in the indicator was noted. In terms of profession, the largest share of seropositive individuals was found among transportation workers; the smallest was found in business. The moderate COVID-19 incidence has not led to a dramatic increase in the number of contacts. The base reproduction number (R0) was 1.3. In the Republic of Belarus, there was a moderate level of asymptomatic COVID-19 among seropositive individuals (45.3% [95% CI 44.0–46.7]). This form of infection was observed most often among children aged 1–17 years old (65.0% [95% CI 61.3–68.6]). In parallel with seroprevalence assessment, SARS-CoV-2 vaccination was carried out. We used two vaccines: Gam-COVID-Vac (also known as Sputnik V, developed by Gamaleya National Center for Epidemiology and Microbiology, Russia); and BBIBP-CorV (Sinopharm, PRC). Vaccination against SARS-CoV-2 was accompanied by an increase in the level of anti-RBD Abs (95% [95% CI 94.7–96.7]). Taking into account the vaccination of a subset of the population with BBIBP-CorV, the overall herd immunity, inferred from the analyzed indicators (presence of anti-Nc or anti-RBD Abs), was 47.1% (95% CI 46.3–48.0). Conclusion. COVID-19 in Belarus was characterized by a moderately pronounced course of the epidemic process. The threshold level of herd immunity to SARS-CoV-2 has not yet been reached, as a result of which the conditions for progression of the epidemic remain.

27 February 2025 in Vaccines
Verified
Journal Article
Open access
PDF file
APAnna Yurievna Popova
Anna Yurievna Popova
VSViacheslav Smirnov
Viacheslav Smirnov
SESvetlana Alexandrovna Egorova
Svetlana Alexandrovna Egorova
ZNZuridin Sharipovich Nurmatov
Zuridin Sharipovich Nurmatov
AMAngelika Marsovna Milichkina
Angelika Marsovna Milichkina
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Specific prevention of measles, mumps, and rubella (MMR) is the main prerequisite for a radical reduction in the incidence of these infections in the Kyrgyz Republic (KR). An increase in the number of seronegative individuals observed in recent years has led to an increase in measles incidence. This is directly related to a decrease in collective immunity, which provides protection for the population only in conditions of a high density of immunized individuals and their uniform distribution in the population. The only way to estimate the number of immunized individuals is by conducting serological surveys of collective immunity. Aim of the study: The aim was to study the level of collective immunity to the MMR viruses in the KR. Materials and methods: This study involved a cohort of 6617 residents (volunteers) aged 1 to 70+ years, formed in accordance with the Rospotrebnadzor program “Assessment of collective immunity to vaccine-preventable and other relevant infections” and stratified by age and region of residence. During the study, participants filled out a questionnaire and gave venous blood samples to determine IgG antibodies to MMR viruses (ELISA using certified Russian test systems). Results: In December 2023, collective immunity ensured epidemiological well-being only with respect to rubella. The volunteer seropositivity was 94.2% (95% CI: 93.7–94.8). The average measles seropositivity was 78.9% (95% CI: 77.9–79.9). It was significantly lower in children aged 1–17 years and significantly higher than the cohort average in individuals aged ≥18 years. The average mumps seropositivity was 76.4% (95% CI: 75.3–77.4), with the minimum level noted among individuals aged 12–29 years (63.8%; 95% CI: 61.4–66.2). The maximum levels of mumps seropositivity were noted among children aged 6–11 years and older adults who had likely experienced mumps (50–70+ years). Seroprevalence distributions by activity correlated with age distributions (all infections). Conclusions: The system of targeted prophylaxis of vaccine-preventable infections adopted in the KR has contributed to the formation of a high level of rubella collective immunity and, to a lesser extent, measles and mumps immunity. The recent trend towards increases in measles and mumps incidence in the KR requires additional efforts to increase collective immunity to these infections.